<DOC>
	<DOCNO>NCT00546169</DOCNO>
	<brief_summary>- Effectiveness reliability TachoSil cholecystectomy ( elective acute ) - Evaluation TachoSil laparoscopic cholecystectomy - Risk profile patient anticoagulant therapy undergo acute cholecystectomy - Pharmaco-economic evaluation - Recording AE's/SAE 's Considering total number cholecystectomy Germany ( 170.000 cases/y ) , 75 % laparoscopic 10.000 conversion totally seem urgent record data usage TachoSil procedure . For time TachoSil apply 2 % gall bladder procedure . Aim evaluate possible patient procedure profile TachoSil beneficial .</brief_summary>
	<brief_title>Non-interventional Trial About Treatment Haemorrhages Cholecystectomy With TachoSil ( TC-027-DE )</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>Patients undergo elective acute cholecystectomy The restriction use result contraindication ( see section 4.3 Summary Product Characteristics )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Patients undergo elective acute cholecystectomy</keyword>
</DOC>